Cosmos Holdings Inc. is a vertically integrated pharmaceutical company. The company is headquartered in Chicago, Illinois.
| Revenue (TTM) | $65.27M |
| Gross Profit (TTM) | $7.90M |
| EBITDA | $-15.18M |
| Operating Margin | -57.10% |
| Return on Equity | -89.10% |
| Return on Assets | -17.30% |
| Revenue/Share (TTM) | $2.15 |
| Book Value | $0.45 |
| Price-to-Book | 1.05 |
| Price-to-Sales (TTM) | 0.28 |
| EV/Revenue | 0.59 |
| EV/EBITDA | -1.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 38.50% |
| Shares Outstanding | $50.83M |
| Float | $36.84M |
| % Insiders | 26.51% |
| % Institutions | 5.93% |
Volatility is currently expanding